nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—Caffeine—PIK3CD—ovarian cancer	0.114	0.286	CrCbGaD
Theobromine—Caffeine—PIK3CB—ovarian cancer	0.114	0.286	CrCbGaD
Theobromine—Caffeine—PIK3CA—ovarian cancer	0.0881	0.221	CrCbGaD
Theobromine—Theophylline—CYP1B1—ovarian cancer	0.0365	0.0916	CrCbGaD
Theobromine—ADORA2A—gonad—ovarian cancer	0.0362	0.0871	CbGeAlD
Theobromine—Caffeine—CYP1B1—ovarian cancer	0.0358	0.09	CrCbGaD
Theobromine—ADORA2A—female reproductive system—ovarian cancer	0.0323	0.0778	CbGeAlD
Theobromine—ADORA1—female reproductive system—ovarian cancer	0.0279	0.0672	CbGeAlD
Theobromine—PDE4B—uterine cervix—ovarian cancer	0.0276	0.0663	CbGeAlD
Theobromine—PDE4B—decidua—ovarian cancer	0.0263	0.0632	CbGeAlD
Theobromine—ADORA2A—testis—ovarian cancer	0.0261	0.0628	CbGeAlD
Theobromine—ADORA1—vagina—ovarian cancer	0.0252	0.0608	CbGeAlD
Theobromine—PDE4B—endometrium—ovarian cancer	0.0249	0.06	CbGeAlD
Theobromine—PDE4B—gonad—ovarian cancer	0.0231	0.0556	CbGeAlD
Theobromine—ADORA1—testis—ovarian cancer	0.0225	0.0542	CbGeAlD
Theobromine—PDE4B—female reproductive system—ovarian cancer	0.0207	0.0497	CbGeAlD
Theobromine—PDE4B—bone marrow—ovarian cancer	0.0195	0.0469	CbGeAlD
Theobromine—PDE4B—female gonad—ovarian cancer	0.0188	0.0452	CbGeAlD
Theobromine—PDE4B—vagina—ovarian cancer	0.0187	0.0449	CbGeAlD
Theobromine—PDE4B—testis—ovarian cancer	0.0167	0.0401	CbGeAlD
Theobromine—ADORA1—lymph node—ovarian cancer	0.0163	0.0393	CbGeAlD
Theobromine—PDE4B—lymph node—ovarian cancer	0.0121	0.0291	CbGeAlD
Theobromine—CYP2E1—female reproductive system—ovarian cancer	0.0114	0.0275	CbGeAlD
Theobromine—Caffeine—ABCB1—ovarian cancer	0.0103	0.0258	CrCbGaD
Theobromine—CYP2E1—testis—ovarian cancer	0.00921	0.0222	CbGeAlD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000362	0.00194	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000362	0.00194	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—YAP1—ovarian cancer	0.000354	0.0019	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—YAP1—ovarian cancer	0.00035	0.00188	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—XIAP—ovarian cancer	0.000347	0.00186	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—XIAP—ovarian cancer	0.000343	0.00184	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000342	0.00184	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—ovarian cancer	0.000341	0.00183	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—SMARCA4—ovarian cancer	0.000338	0.00182	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—TP53—ovarian cancer	0.000337	0.00181	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—SMARCA4—ovarian cancer	0.000334	0.00179	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—STAT3—ovarian cancer	0.000333	0.00179	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—NRAS—ovarian cancer	0.000332	0.00178	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EREG—ovarian cancer	0.00033	0.00177	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EREG—ovarian cancer	0.000326	0.00175	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—MAPK3—ovarian cancer	0.000318	0.00171	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—ovarian cancer	0.000316	0.00169	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PGR—ovarian cancer	0.00031	0.00166	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HDAC6—ovarian cancer	0.000309	0.00166	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—IL6—ovarian cancer	0.000308	0.00165	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PGR—ovarian cancer	0.000306	0.00164	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PPP2R1A—ovarian cancer	0.000305	0.00164	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000304	0.00163	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—MAPK1—ovarian cancer	0.000302	0.00162	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—EGFR—ovarian cancer	0.000302	0.00162	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—ovarian cancer	0.000302	0.00162	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—CXCL8—ovarian cancer	0.000293	0.00157	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000291	0.00156	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000291	0.00156	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000288	0.00154	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PARP1—ovarian cancer	0.000288	0.00154	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—KRAS—ovarian cancer	0.000286	0.00153	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PARP1—ovarian cancer	0.000284	0.00153	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—ovarian cancer	0.000279	0.0015	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL6ST—ovarian cancer	0.000275	0.00148	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—YAP1—ovarian cancer	0.000274	0.00147	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL6ST—ovarian cancer	0.000272	0.00146	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—XIAP—ovarian cancer	0.000268	0.00144	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—PIK3CG—ovarian cancer	0.000264	0.00142	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—PIK3CA—ovarian cancer	0.000262	0.00141	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—PIK3CG—ovarian cancer	0.000261	0.0014	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—SMARCA4—ovarian cancer	0.000261	0.0014	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYTB—ovarian cancer	0.000258	0.00138	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000256	0.00137	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EREG—ovarian cancer	0.000255	0.00137	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000253	0.00136	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—HRAS—ovarian cancer	0.000243	0.0013	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NME2—ovarian cancer	0.00024	0.00129	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PGR—ovarian cancer	0.000239	0.00128	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PPP2R1A—ovarian cancer	0.000233	0.00125	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—PIK3CD—ovarian cancer	0.000233	0.00125	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—IL6—ovarian cancer	0.000232	0.00125	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PPP2R1A—ovarian cancer	0.000231	0.00124	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—PIK3CD—ovarian cancer	0.00023	0.00123	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—BRIP1—ovarian cancer	0.000225	0.00121	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	0.000225	0.00121	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—PIK3CG—ovarian cancer	0.000225	0.00121	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000223	0.0012	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PARP1—ovarian cancer	0.000222	0.00119	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000221	0.00118	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—CXCL8—ovarian cancer	0.000214	0.00115	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—AKT1—ovarian cancer	0.000214	0.00115	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL6ST—ovarian cancer	0.000213	0.00114	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—CXCL8—ovarian cancer	0.000212	0.00114	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—IL2—ovarian cancer	0.000205	0.0011	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CG—ovarian cancer	0.000204	0.0011	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000204	0.00109	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—PIK3CB—ovarian cancer	0.000203	0.00109	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—IL2—ovarian cancer	0.000203	0.00109	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—PIK3CB—ovarian cancer	0.0002	0.00107	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—PIK3CD—ovarian cancer	0.000198	0.00106	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—CXCL8—ovarian cancer	0.000195	0.00105	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—CXCL8—ovarian cancer	0.000192	0.00103	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL2—ovarian cancer	0.000186	0.000999	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TERT—ovarian cancer	0.000185	0.000995	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL2—ovarian cancer	0.000184	0.000987	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TERT—ovarian cancer	0.000183	0.000983	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PPP2R1A—ovarian cancer	0.00018	0.000967	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CD—ovarian cancer	0.00018	0.000964	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	0.000172	0.000925	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CAV1—ovarian cancer	0.000172	0.000921	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CAV1—ovarian cancer	0.000169	0.00091	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000166	0.000893	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—CXCL8—ovarian cancer	0.000166	0.000889	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ESR1—ovarian cancer	0.000165	0.000887	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ESR1—ovarian cancer	0.000163	0.000877	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6ST—ovarian cancer	0.000163	0.000873	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6ST—ovarian cancer	0.000161	0.000862	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—IL2—ovarian cancer	0.000158	0.000849	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CB—ovarian cancer	0.000156	0.00084	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—APC—ovarian cancer	0.000156	0.000839	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CG—ovarian cancer	0.000156	0.000839	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—NRAS—ovarian cancer	0.000156	0.000839	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYTB—ovarian cancer	0.000155	0.000832	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—APC—ovarian cancer	0.000154	0.000829	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CG—ovarian cancer	0.000154	0.000829	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—NRAS—ovarian cancer	0.000154	0.000829	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000151	0.000813	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—YAP1—ovarian cancer	0.000151	0.000811	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—CXCL8—ovarian cancer	0.00015	0.000807	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—MAPK3—ovarian cancer	0.00015	0.000803	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—MAPK3—ovarian cancer	0.000148	0.000794	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL2—ovarian cancer	0.000144	0.000771	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TERT—ovarian cancer	0.000143	0.000768	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—MAPK1—ovarian cancer	0.000142	0.000764	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—EGFR—ovarian cancer	0.000142	0.000764	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—MAPK1—ovarian cancer	0.000141	0.000755	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—EGFR—ovarian cancer	0.000141	0.000755	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CD—ovarian cancer	0.000137	0.000737	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000136	0.00073	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CD—ovarian cancer	0.000136	0.000728	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	0.000135	0.000727	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—BRIP1—ovarian cancer	0.000135	0.000727	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—KRAS—ovarian cancer	0.000134	0.000722	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000134	0.000722	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—KRAS—ovarian cancer	0.000133	0.000713	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CAV1—ovarian cancer	0.000132	0.000711	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ESR1—ovarian cancer	0.000128	0.000685	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6ST—ovarian cancer	0.000126	0.000674	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—PIK3CA—ovarian cancer	0.000124	0.000663	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—FASN—ovarian cancer	0.000123	0.000661	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—PIK3CA—ovarian cancer	0.000122	0.000655	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ERBB2—ovarian cancer	0.000121	0.000651	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	0.000121	0.00065	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—APC—ovarian cancer	0.000121	0.000647	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CG—ovarian cancer	0.000121	0.000647	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—NRAS—ovarian cancer	0.000121	0.000647	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ERBB2—ovarian cancer	0.00012	0.000643	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MTOR—ovarian cancer	0.00012	0.000643	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CB—ovarian cancer	0.00012	0.000643	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MTOR—ovarian cancer	0.000118	0.000635	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CB—ovarian cancer	0.000118	0.000635	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	0.000117	0.000628	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—MAPK3—ovarian cancer	0.000116	0.00062	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CXCL8—ovarian cancer	0.000115	0.000617	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HRAS—ovarian cancer	0.000114	0.000613	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CXCL8—ovarian cancer	0.000114	0.00061	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HRAS—ovarian cancer	0.000113	0.000606	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CDKN1B—ovarian cancer	0.000112	0.000603	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	0.000112	0.000602	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—AKT1—ovarian cancer	0.000111	0.000597	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CDKN1B—ovarian cancer	0.000111	0.000596	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CASP3—ovarian cancer	0.00011	0.000591	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL2—ovarian cancer	0.00011	0.00059	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—MAPK1—ovarian cancer	0.00011	0.00059	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—EGFR—ovarian cancer	0.00011	0.00059	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—AKT1—ovarian cancer	0.00011	0.000589	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL6—ovarian cancer	0.000109	0.000587	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CASP3—ovarian cancer	0.000109	0.000584	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL2—ovarian cancer	0.000109	0.000583	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL6—ovarian cancer	0.000108	0.00058	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCND1—ovarian cancer	0.000107	0.000575	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CTNNB1—ovarian cancer	0.000106	0.00057	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CD—ovarian cancer	0.000106	0.000569	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCND1—ovarian cancer	0.000106	0.000568	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	0.000105	0.000564	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CTNNB1—ovarian cancer	0.000105	0.000563	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MMP9—ovarian cancer	0.000104	0.000559	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—KRAS—ovarian cancer	0.000104	0.000557	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PTEN—ovarian cancer	0.000103	0.000555	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MMP9—ovarian cancer	0.000103	0.000552	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PTEN—ovarian cancer	0.000102	0.000549	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—AKT1—ovarian cancer	0.000101	0.000542	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—AKT1—ovarian cancer	9.97e-05	0.000535	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	9.95e-05	0.000534	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.87e-05	0.00053	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CA—ovarian cancer	9.54e-05	0.000512	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ERBB2—ovarian cancer	9.37e-05	0.000503	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—VEGFA—ovarian cancer	9.34e-05	0.000502	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—STAT3—ovarian cancer	9.25e-05	0.000497	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MTOR—ovarian cancer	9.24e-05	0.000496	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CB—ovarian cancer	9.24e-05	0.000496	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ABCB1—ovarian cancer	9.24e-05	0.000496	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—VEGFA—ovarian cancer	9.23e-05	0.000496	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—NRAS—ovarian cancer	9.23e-05	0.000495	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—STAT3—ovarian cancer	9.14e-05	0.000491	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—NRAS—ovarian cancer	9.12e-05	0.000489	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—YAP1—ovarian cancer	9.08e-05	0.000488	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—TYMS—ovarian cancer	9.07e-05	0.000487	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.99e-05	0.000483	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CXCL8—ovarian cancer	8.88e-05	0.000477	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK3—ovarian cancer	8.84e-05	0.000474	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HRAS—ovarian cancer	8.82e-05	0.000474	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK3—ovarian cancer	8.73e-05	0.000469	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CDKN1B—ovarian cancer	8.67e-05	0.000466	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MYC—ovarian cancer	8.6e-05	0.000461	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—AKT1—ovarian cancer	8.58e-05	0.000461	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CASP3—ovarian cancer	8.5e-05	0.000456	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MYC—ovarian cancer	8.49e-05	0.000456	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL2—ovarian cancer	8.49e-05	0.000456	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL6—ovarian cancer	8.45e-05	0.000453	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK1—ovarian cancer	8.41e-05	0.000451	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EGFR—ovarian cancer	8.41e-05	0.000451	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK1—ovarian cancer	8.31e-05	0.000446	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EGFR—ovarian cancer	8.31e-05	0.000446	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCND1—ovarian cancer	8.28e-05	0.000444	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CTNNB1—ovarian cancer	8.19e-05	0.00044	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MMP9—ovarian cancer	8.03e-05	0.000431	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PTEN—ovarian cancer	7.99e-05	0.000429	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—KRAS—ovarian cancer	7.94e-05	0.000426	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.9e-05	0.000424	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—KRAS—ovarian cancer	7.85e-05	0.000421	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—AKT1—ovarian cancer	7.79e-05	0.000418	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—FASN—ovarian cancer	7.41e-05	0.000397	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CAV1—ovarian cancer	7.31e-05	0.000392	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CA—ovarian cancer	7.3e-05	0.000392	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	7.28e-05	0.000391	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—VEGFA—ovarian cancer	7.21e-05	0.000387	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CA—ovarian cancer	7.21e-05	0.000387	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—STAT3—ovarian cancer	7.14e-05	0.000383	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NRAS—ovarian cancer	7.13e-05	0.000382	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TP53—ovarian cancer	7.06e-05	0.000379	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	7.04e-05	0.000378	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TP53—ovarian cancer	6.98e-05	0.000374	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.89e-05	0.00037	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK3—ovarian cancer	6.82e-05	0.000366	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HRAS—ovarian cancer	6.75e-05	0.000362	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	6.74e-05	0.000362	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HRAS—ovarian cancer	6.67e-05	0.000358	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	6.66e-05	0.000357	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MYC—ovarian cancer	6.64e-05	0.000356	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK1—ovarian cancer	6.49e-05	0.000349	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EGFR—ovarian cancer	6.49e-05	0.000348	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6—ovarian cancer	6.46e-05	0.000347	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6—ovarian cancer	6.39e-05	0.000343	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KRAS—ovarian cancer	6.13e-05	0.000329	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	5.98e-05	0.000321	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—AKT1—ovarian cancer	5.96e-05	0.00032	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.95e-05	0.00032	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—AKT1—ovarian cancer	5.89e-05	0.000316	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	5.86e-05	0.000314	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CA—ovarian cancer	5.63e-05	0.000302	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCB1—ovarian cancer	5.55e-05	0.000298	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TYMS—ovarian cancer	5.46e-05	0.000293	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TP53—ovarian cancer	5.45e-05	0.000293	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HRAS—ovarian cancer	5.21e-05	0.00028	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	5.1e-05	0.000274	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6—ovarian cancer	4.99e-05	0.000268	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—AKT1—ovarian cancer	4.6e-05	0.000247	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTEN—ovarian cancer	4.41e-05	0.000237	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CAV1—ovarian cancer	4.4e-05	0.000236	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.2e-05	0.000225	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4e-05	0.000215	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.52e-05	0.000189	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.11e-05	0.000167	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.07e-05	0.000165	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTEN—ovarian cancer	2.65e-05	0.000142	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—AKT1—ovarian cancer	2.54e-05	0.000136	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.87e-05	0.0001	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.53e-05	8.2e-05	CbGpPWpGaD
